These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Current concepts and controversies in the pathogenesis, prevention, and treatment of the macrovascular complications of diabetes. Mazzone T J Lab Clin Med; 2000 Jun; 135(6):437-43. PubMed ID: 10850642 [No Abstract] [Full Text] [Related]
5. Atherosclerosis, the major complication of diabetes. Steiner G Adv Exp Med Biol; 1985; 189():277-97. PubMed ID: 4036715 [No Abstract] [Full Text] [Related]
6. Endothelial dysfunction, insulin resistance and diabetes: exploring the web of causality. Playford D; Watts GF Aust N Z J Med; 1999 Aug; 29(4):523-34. PubMed ID: 10868531 [No Abstract] [Full Text] [Related]
7. Obesity, atherosclerosis and diabetes mellitus. Björntorp P Verh Dtsch Ges Inn Med; 1987; 93():443-8. PubMed ID: 3327295 [No Abstract] [Full Text] [Related]
8. [Diabetes and atherosclerosis. Physiopathology of diabetic macroangiopathy]. Leutenegger M Rev Med Interne; 1994; 15 Suppl 3():270S-273S. PubMed ID: 7863131 [No Abstract] [Full Text] [Related]
9. [Type II diabetes and hypertension]. Peters A; Kerner W Med Klin (Munich); 1996 Oct; 91(10):640-5. PubMed ID: 9019641 [No Abstract] [Full Text] [Related]
10. Vascular insulin abnormalities, hypertension, and accelerated atherosclerosis. Standley PR; Bakir MH; Sowers JR Am J Kidney Dis; 1993 Jun; 21(6 Suppl 3):39-46. PubMed ID: 8503434 [TBL] [Abstract][Full Text] [Related]
11. [The arterial wall, insulin, diabetes and atherosclerosis]. Capron L; Fiessinger JN; Housset E Journ Annu Diabetol Hotel Dieu; 1982; ():247-55. PubMed ID: 7047840 [No Abstract] [Full Text] [Related]
12. Post-prandial hyperglycaemia and vascular disease. Hanefeld M Int J Clin Pract Suppl; 2000 Sep; (112):13-8. PubMed ID: 11064946 [No Abstract] [Full Text] [Related]
13. [Patomechanism of diabetic macroangiopathy. The role of calcium-sensing receptor (CaR)]. Małecki R; Adamiec R Pol Arch Med Wewn; 2004 Jul; 112(1):879-84. PubMed ID: 15526852 [No Abstract] [Full Text] [Related]
14. [Lipid metabolism and insulin resistance--clinical aspects and pathobiochemistry]. Gries FA; Hübinger A Wien Klin Wochenschr; 1994; 106(24):763-7. PubMed ID: 7846895 [TBL] [Abstract][Full Text] [Related]
15. Fibrinogen, fibrinolysis and diabetes mellitus: a comment. Vague P; Juhan-Vague I Diabetologia; 1997 Jun; 40(6):738-40. PubMed ID: 9222657 [No Abstract] [Full Text] [Related]
16. Pathogenesis of hypertension in diabetes. Stas SN; El-Atat FA; Sowers JR Rev Endocr Metab Disord; 2004 Aug; 5(3):221-5. PubMed ID: 15211093 [No Abstract] [Full Text] [Related]
17. Pathophysiological implications of insulin resistance on vascular endothelial function. Wheatcroft SB; Williams IL; Shah AM; Kearney MT Diabet Med; 2003 Apr; 20(4):255-68. PubMed ID: 12675638 [TBL] [Abstract][Full Text] [Related]
18. [Hypertension in metabolic syndrome. Etiology and consequences]. Rett K Fortschr Med; 1992 Dec; 110(34):642-4. PubMed ID: 1483616 [TBL] [Abstract][Full Text] [Related]
19. Features of macrovascular complications in type 2 diabetic patients. Strojek K Acta Diabetol; 2003 Dec; 40 Suppl 2():S334-7. PubMed ID: 14704864 [TBL] [Abstract][Full Text] [Related]
20. Intracellular starvation in the insulin resistance syndrome and type II diabetes mellitus. Fournier AM Med Hypotheses; 1998 Aug; 51(2):95-9. PubMed ID: 9881813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]